Innovation Pharmaceuticals Inc (IPIX)

[MinnieM]

The FDA wanted Brilacidin tested against Daptomycin in the 2B since Daptomycin was used in the 2A. We basically did a dose optimization study. The drug had to be the same.

Here's the 2A:
https://clinicaltrials.gov/ct2/show/NCT01211470?term=pmx30063&rank=1

We should be finding out about the phase III and what the FDA wants soon enough. It may end up comparing Brilacidin to Vancomycin. ;)





In Reply to 'Dr Jerry'
Market makers cleaned out all the stop loss orders today cleaning up on another million shares at bargain prices.
Leo will release phase 2b bottom line data on monday, mark this post.
The man will also probably announce mechanics of the phase 3 trial.
I think the delay is because the FDA would like to compare Brilacidin to the current drug of choice Vancomycin.
If B can take on and out perform Vancomycin it would guarantee a Fast Track designation.
Daptomycin is not the current drug of choice and people here forget to check the facts.
Leo and Menon must go toe to toe in phase 3 with Vancomycin.
They will beat V hands down...